Monday, December 22, 2025
Onboard AI has revealed a new strategic investment and collaboration with Cedars-Sinai, marking a significant step toward strengthening responsible AI adoption in healthcare. Through this partnership, Cedars-Sinai will implement Onboard AI’s automated, AI-native governance platform, which is built to help health systems evaluate, approve, and continuously monitor AI solutions with greater speed and consistency. With this deployment, Onboard AI aims to equip medical providers with the tools they need to accelerate innovation while ensuring every solution is safe, effective, and trustworthy.
Healthcare organizations today face an unprecedented surge of AI offerings. As technology companies rapidly develop AI-driven tools, hospitals must carefully review each solution to ensure accuracy, fairness, and reliability across various clinical and operational environments. This growing influx has overwhelmed many health systems, leading to long approval cycles, inconsistent review procedures, and delays that ultimately slow AI adoption. Onboard AI positions its platform as the answer to this increasingly complex challenge.
The company’s vision gained further credibility through Cedars-Sinai’s decision to onboard the platform. Emphasizing the importance of this collaboration, Troy Bannister, CEO of Onboard AI, stated, "Our platform is already live at leading hospitals across the U.S., and Cedars-Sinai's partnership validates why. They chose us because we are AI-native, automated, and designed for both AI implementers and developers. Together, we're creating a system every healthcare organization can rely on to adopt AI responsibly and at scale."
Cedars-Sinai has already integrated numerous AI tools to enhance patient outcomes, improve diagnostics, accelerate research, and streamline workflows. Yet, the organization recognizes that as AI innovation expands, the responsibility to manage and govern these technologies becomes even more important. Consistent governance ensures that each AI solution not only delivers value but also aligns with strict safety and ethical standards.
Onboard AI’s approach replaces traditional manual reviews with AI-driven workflows that automatically assess key performance and risk factors. Every AI solution undergoes evaluation for fairness, clinical safety, accuracy, and overall effectiveness. As a result, health systems can reduce approval backlogs, eliminate inconsistencies, and create a scalable process that supports faster, responsible integration of AI-powered healthcare tools.
Highlighting the importance of trust in AI adoption, Mouneer Odeh, Chief Data and AI Officer at Cedars-Sinai, explained, "Responsible AI isn't just about speed - it's about trust. With Onboard AI, we're scaling innovation by ensuring every solution meets our rigorous standards for safety and ethics. That's how we build confidence in the future of healthcare."
This partnership signals a broader shift in the healthcare industry—one where rapid AI growth must be matched with strong, automated governance and oversight. As more hospitals face increasing pressure to evaluate complex AI tools quickly and safely, platforms like Onboard AI are becoming essential infrastructure for the next era of digital healthcare.
To join our expert panel discussions, reach out to info@intentamplify.com
Contact Center Technology Insights:
Tags:
Infobip partners with North American telecoms to standardize Branded Calling ID™, helping businesses combat spam calls and restore customer trust nationwide.
Conservation X Labs and Meta release the largest open dataset of annotated wildlife camera trap videos, featuring 10,000 clips and nearly 100 species worldwide.
